Jane Cullis is a science advisor in the firm’s Litigation Department and a member of its Intellectual Property practice. She contributes to the firm’s work in patent litigation, patent opinions and due diligence. Dr. Cullis is an editor and contributor to the firm’s award-winning biosimilars blog, Big Molecule Watch.

Dr. Cullis obtained her Ph.D. in Medical Biophysics from the University of Toronto under the supervision of Dr. Robert Rottapel. Dr. Cullis’ thesis focused on deciphering signaling pathways regulated by the RAS oncogene, which is mutated in over 90% of pancreatic cancers. Dr. Cullis’ research identified the Rho guanine nucleotide exchange factor GEF-H1 as a critical amplifier of oncogenic signaling in animal models of pancreatic cancer. Dr. Cullis’ work was published in the journal Cancer Cell in 2014 and was awarded the Ontario Cancer Institute and Princess Margaret Hospital paper of the year.

Dr. Cullis continued her research in pancreatic cancer as a postdoctoral fellow at the New York University School of Medicine under the supervision of Dr. Dafna Bar-Sagi. There, Dr. Cullis identified a novel mechanism of action of the FDA-approved drug nanoparticle albumin-bound-paclitaxel (nab-paclitaxel, trade name Abraxane) on macrophages, the predominant immune cell type in pancreatic tumors. Dr. Cullis found that macrophages internalize and are activated by nab-paclitaxel, resulting in a tumor cell cytotoxic phenotype. Dr. Cullis’ work was featured on the cover of the journal Cancer Immunology Research in 2017, and NYU School of Medicine named Dr. Cullis Outstanding Postdoctoral Scholar of the Year.

Dr. Cullis was supported by the Ontario Graduate Scholarships in Science and Technology, Edward Dunlop Foundation Award (2007-2011), the McCuaig-Throop Bursary (2008), and the Ontario Student Opportunities Trust Fund Award (2007) from the University of Toronto throughout her graduate studies. Dr. Cullis’ postdoctoral research was funded by the Molecular Oncology and Immunology Training Grant (2013-2015) and the Immunology and Inflammation Training Grant (2016-2017) from the NYU School of Medicine.

Areas of Practice
Domaines D’Expertise





Ms. Cullis has been involved in various stages of patent litigation, including discovery, motion practice, and pretrial proceedings. Some of her recent engagements include:

  • Representing defendant Pass & Seymour in a long-running dispute involving P&S’s core technology, ground-fault circuit interrupters (GFCIs).
Professional Experience

In addition to Dr. Cullis’ research experience, she was co-founder and director of the NYU School of Medicine Women in Science group and serves as a science advisor on the research committee of the nonprofit organization for pancreatic cancer, Project Purple.

In The News









Ph.D., Medical Biophysics, 2013
University of Toronto
B.Sc., Biochemistry, 2006
McGill University
(Great Distinction)
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique